Press Release: OncoSec Collaborates with Smart Patients
ONCOSEC
We are a biotech company developing treatments for advanced-stage skin cancer. Our noninvasive therapies destroy solid tumors and metastatic cancer and preserve quality of life.
IMMUNOPULSE
ImmunoPulse uses DNA IL-12 to stimulate the body’s immune system and enables it to recognize, target, and destroy cancerous cells.
NEOPULSE
NeoPulse boosts the effectiveness of cancer drug bleomycin by a factor of several thousand, enabling highly effective, less-debilitating treatment.